Transcription of Product Information 2x Laemmli Sample 2x …
{{id}} {{{paragraph}}}
2x Laemmli Sample BufferCatalog #161-07374x Laemmli Sample BufferCatalog #161-0747 Product InformationCatalog # DescriptionPremixed Sample Buffers161-0737 2x Laemmli Sample buffer , 30 ml161-0747 4x Laemmli Sample buffer , 10 ml161-0710 2-Mercaptoethanol, 25 ml161-0738 Native Sample buffer , 30 ml161-0739 Tricine Sample buffer , 30 ml161-0767 5x Nucleic Acid Sample buffer , 10 ml161-0768 TBE-Urea Sample buffer , 30 ml161-0763 IEF Sample buffer , 30 ml161-0764 Zymogram Sample buffer , 30 ml Premixed Buffers161-0732 10x Tris/Glycine/SDS, 1 L161-0772 10x Tris/Glycine/SDS, 5 L161-0734 10x Tris/Glycine, 1 L161-0771 10x Tris/Glycine, 5 LBio-Rad Laboratories, Alfred Nobel Dr., Hercules, CA 94547 USA 510-741-1000 4006028 Rev JIntroductionBio-Rad s Laemmli Sample buffers are based on the method of Laemmli (1970).
2x Laemmli Sample Buffer Catalog #161-0737 4x Laemmli Sample Buffer Catalog #161-0747 Product Information Catalog # Description Premixed Sample Buffers
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Transfer Buffer Formulations, INJECTABLE DRUG DELIVERY 2013:, INJECTABLE DRUG DELIVERY 2013: FORMULATIONS FOCUS, FormulatIons, Extemporaneous formulations of Oral Liquids, ADDITIVES FOR Specialty Chemistry Formulations, ADDITIVES FOR Specialty Chemistry Formulations PER FUNCTION, InnovatIve strategIes for stabIlIzatIon formulatIons, InnovatIve strategIes for stabIlIzatIon, Validation of Related Substances, Validation of Related Substances Method, Development and Validation of In Vitro Release